The Market Ticker
Commentary on The Capital Markets

Now this is rich...

Citing “security reasons,” the Pakistani government plans to prevent its citizens from accessing BlackBerry’s suite of secure messaging services by December 1, according to a report fromReuters.

“[The Pakistan Telecommunication Authority] has issued directions to local mobile phone operators to close BlackBerry Enterprise Services from Nov. 30 on security reasons,” said an unnamed Pakistani official to the publication.

Uh huh.

The truth is, as BlackBerry explains, that Pakistan demanded a back door into the firm's BES services -- and BlackBerry refused.

Pakistan wouldn't have asked if they could have broken in without BlackBerry's help, by the way.

In light of this admission and public position, backed up by acts instead of rhetoric, which company would you like to buy your phone and mobile management service from?  Psst... don't read this article... smiley

View this entry with comments (registration required to post)
 

Hmmmm...

President Obama on Saturday made an personal plea for gay rights during his visit to Kenya, warning that “bad things happen” when countries discriminate against certain groups of people.

“As an African-American in the United States, I am painfully aware of the history of what happens when people are treated differently under the law,” Obama added during a joint press conference with Kenyan President Uhuru Kenyatta. “I’m unequivocal on this.”

But Obama’s call for universal gay rights was quickly dismissed by Kenyatta, who described the issue as something “our culture, our society does not accept.”“For Kenyans today, the issue of gay rights is really a non-issue. We want to focus on other areas that are day-to-day living for our people,” he said, citing heath concerns and women’s rights.

It's always amusing to see our nation try to shove its views down someone else's throat.  The pushback on this one, however, was foretold as it was expected the Kenyan government wasn't going to just roll over and take the lashing from Obama, even though I suspect he thought he could get away with it unchallenged.

Uh, nope.  

Maybe -- just maybe, the Kenyans are on to something...

View this entry with comments (registration required to post)
 

2015-07-27 10:12 by Karl Denninger
in Social Issues , 256 references
 

I cannot vouch for this.

The site on which it appeared (it has been picked up a few other places) has a definite slant.  Then again, we all have slants.  The question isn't whether there's editorial slant, it's whether there is truth presented on the page.  Those of you inclined to discount this due to the source are welcome to do so but this is a first-party account of alleged facts backed up by actual criminal convictions, not an anecdote.

I was born into a family of famous gay pagan authors in the late Sixties. My mother was Marion Zimmer Bradley, and my father was Walter Breen. Between them, they wrote over 100 books: my mother wrote science fiction and fantasy (Mists of Avalon), and my father wrote books on numismatics: he was a coin expert.

What they did to me is a matter of unfortunate public record: suffice to say that both parents wanted me to be gay and were horrifed at my being female. My mother molested me from ages 3-12. The first time I remember my father doing anything especially violent to me I was five. Yes he raped me. I don’t like to think about it. If you want to know about his shenanigans with little girls, and you have a very strong stomach, you can google the Breendoggle, which was the scandal which ALMOST drummed him out of science fiction fandom.

Read the entire article.

Have a full glass of whatever adult beverage you prefer in-hand first.

Another article, which the US Press appears to have ignored (gee, I wonder why, other than an apologist-style article in WaPo that is not worth my citation) is found here.

View this entry with comments (registration required to post)
 

2015-07-27 08:31 by Karl Denninger
in Macro Factors , 138 references
 

From the Census Bureau....

New orders for manufactured durable goods in June increased $7.7 billion or 3.4 percent to $235.3 billion, the U.S. Census Bureau announced today. This increase, up following two consecutive monthly decreases, followed a 2.1 percent May decrease. Excluding transportation, new orders increased 0.8 percent. Excluding defense, new orders increased 3.8 percent.

Transportation equipment, also up following two consecutive monthly decreases, led the increase, $6.4 billion or 8.9 percent to $78.4 billion.

The internals are about as expected; whether this is a relief snapback for a month after the two months of bad numbers is an unknown; the "all other" category, which is very broad was up 0.4% as well.

There's not much to say on this one other than let's see what next month looks like.

View this entry with comments (registration required to post)
 

There's a new Cholesterol drug on the market from Regeneron that is supposed to low cholesterol in those people who either can't take statins (because of their side effects) or can't take enough of them (for the same reason.)

The problem with this drug is that the screamers are all still talking about how cholesterol is the cause of problems in the body and the Regeneron CEO is on the boob this morning touting his "invention."

The evidence doesn't point this way; cholesterol is not only necessary for all animal life the "lipid hypothesis" was known to be flawed (if not entire bogus) 50 years ago when it was first pushed on the public!

The real problem appears to be not cholesterol but inflammation, and while you can certainly come up with ways to lower cholesterol if you don't address the inflammation then you don't change outcomes materially and if you do address inflammation you don't need to lower cholesterol at all.

There are a small number of people who have hypo cholesterol naturally and some of the outcomes are really awful.  Like, for instance, cerebral hemorrhages -- which kill roughly half of everyone who has one within 30 days.  Here is what the NIH has to say about the potential risks that are being almost-entirely ignored by the screamers producing and selling these drugs:

Lipid lowering drugs, particularly statins, are being more widely used to reduce the cardiovascular mortality. Recent studies show that cardiovascular risk reduction is proportional to the level of reduction of LDL. Therefore the American National Cholesterol Education Program recommends a more aggressive lipid lowering strategy for high risk patients with cardiovascular disease. This means that LDL should be <70mg/dl (1.81 mmol/l). Although cholesterol lowering to this degree is more cardioprotective in high risk patients, other possible complications may neutralize or even outweigh this benefit. For example; hypocholesterolemia was associated with increased risk of colorectal cancer [36], endometrial cancer [37], and liver cancer [40]. Furthermore, some other studies directly link the use of lipid lowering drugs to cancer development. The CARE trial, showed a significant increase in breast cancer [42], while the trial of Pravastatin in elderly individuals at risk of vascular disease (PROSPER) concluded that the significant increase in cancer mortality counterbalanced the benefit of fewer cardiovascular deaths [43]. Moreover; high cholesterol has been found to be protective against intra cerebral hemorrhage [76–78], therefore lipid-lowering medications may increase the risk of ICH (at least theoretically), and several studies have demonstrated that hypocholesterolemia is a risk factor for ICH [73–75].

Given the evidence that points to cholesterol not in fact being the cause of said cardiovascular disease in the first place would we not be better off addressing causes rather than putting band-aids on sucking chest wounds -- especially when the expense comes not only from the drug's cost but also the mortality and morbidity that wind up among the "side effects"?

View this entry with comments (registration required to post)
 

Main Navigation
MUST-READ Selection:
Why I Find It Hard To Give A F**k

Full-Text Search & Archives
Archive Access
Legal Disclaimer

The content on this site is provided without any warranty, express or implied. All opinions expressed on this site are those of the author and may contain errors or omissions.

NO MATERIAL HERE CONSTITUTES "INVESTMENT ADVICE" NOR IS IT A RECOMMENDATION TO BUY OR SELL ANY FINANCIAL INSTRUMENT, INCLUDING BUT NOT LIMITED TO STOCKS, OPTIONS, BONDS OR FUTURES.

The author may have a position in any company or security mentioned herein. Actions you undertake as a consequence of any analysis, opinion or advertisement on this site are your sole responsibility.

Market charts, when present, used with permission of TD Ameritrade/ThinkOrSwim Inc. Neither TD Ameritrade or ThinkOrSwim have reviewed, approved or disapproved any content herein.

The Market Ticker content may be reproduced or excerpted online for non-commercial purposes provided full attribution is given and the original article source is linked to. Please contact Karl Denninger for reprint permission in other media or for commercial use.

Submissions or tips on matters of economic or political interest may be sent "over the transom" to The Editor at any time. To be considered for publication your submission must include full and correct contact information and be related to an economic or political matter of the day. All submissions become the property of The Market Ticker.